B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Gsk 461364

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Gsk 461364, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ruboxistaurin
37 shared targets
bi
30 shared targets
ruxolitinib
32 shared targets
dovitinib
39 shared targets
r
51 shared targets
tg100
22 shared targets
pha
33 shared targets
midostaurin
41 shared targets
su
46 shared targets
fedratinib
51 shared targets
Loading evidence profile...

This evidence profile for Gsk 461364 is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.